Molecular TherapyMolecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938.Molecular Therapy — Methods & Clinical DevelopmentsThe aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella.Topics of particular interest within the journal''s scope include:Gene vector engineering and productionMethods for targeted genome editing and engineeringMethods and technology development for cell reprogramming and directed differentiation of pluripotent cellsMethods for gene and cell vector deliveryDevelopment of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicineAnalysis of gene and cell vector biodistribution and trackingPharmacology/toxicology studies of new and next-generation vectorsMethods for cell isolation, engineering, culture, expansion, and transplantationCell processing, storage, and banking for therapeutic applicationPreclinical and QC/QA assay developmentTranslational and clinical scale-up and Good Manufacturing procedures and process developmentClinical protocol developmentComputational and bioinformatic methods for analysis, modeling, or visualization of biological dataNegotiating the regulatory approval process and obtaining such approval for clinical trials

分子治療《分子療法》雜志是基因轉(zhuǎn)移、載體開(kāi)發(fā)與設(shè)計(jì)、干細(xì)胞操作、基因、肽、蛋白、寡核苷酸的開(kāi)發(fā)、細(xì)胞療法、疫苗開(kāi)發(fā)、臨床前目標(biāo)驗(yàn)證、安全性/有效性研究和臨床試驗(yàn)等領(lǐng)域的領(lǐng)先期刊。分子療法致力于促進(jìn)遺傳學(xué)、醫(yī)學(xué)和生物技術(shù)的科學(xué)發(fā)展。出版重要的同行評(píng)審研究和前沿評(píng)論和評(píng)論，該雜志繼續(xù)吸引該領(lǐng)域的最佳材料。分子治療2015年影響因子為6.938。分子治療-方法和臨床發(fā)展分子治療方法和臨床發(fā)展的目標(biāo)是建立在分子治療的成功之上，在分子治療的保護(hù)傘下發(fā)表重要的同行評(píng)審的方法和程序，以及在廣泛領(lǐng)域的轉(zhuǎn)化進(jìn)展。在期刊范圍內(nèi)特別感興趣的主題包括:基因載體工程與生產(chǎn)靶向基因組編輯和工程方法多能細(xì)胞重編程和定向分化的方法與技術(shù)發(fā)展基因和細(xì)胞載體傳遞的方法用于基因、細(xì)胞治療和再生醫(yī)學(xué)的生物材料和納米顆粒的開(kāi)發(fā)分析基因和細(xì)胞載體的生物分布和跟蹤新型和下一代載體的藥理學(xué)/毒理學(xué)研究細(xì)胞分離、工程、培養(yǎng)、擴(kuò)增和移植的方法細(xì)胞加工、儲(chǔ)存和貯存，用于治療臨床前和QC/QA分析開(kāi)發(fā)轉(zhuǎn)化和臨床推廣以及良好的生產(chǎn)流程和工藝開(kāi)發(fā)臨床協(xié)議開(kāi)發(fā)用于分析、建模或可視化生物數(shù)據(jù)的計(jì)算方法和生物信息學(xué)方法談判監(jiān)管審批流程，并獲得臨床試驗(yàn)的批準(zhǔn)